A Look At Synchrony Financial’s Valuation As CareCredit Expands On Walmartcom And New Initiatives Roll Out

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

Synchrony Financial (SYF) is drawing fresh attention after expanding CareCredit acceptance to eligible health and wellness purchases on Walmart.com, alongside new financial literacy initiatives and rising analyst optimism ahead of upcoming first quarter results.

See our latest analysis for Synchrony Financial.

The recent CareCredit expansion on Walmart.com and new partnerships in pet health and financial education arrive as the 1-year total shareholder return sits at 57.38% and the 3-year total shareholder return at 157.34%, even as the 90-day share price return of a 21.71% decline and the year-to-date share price return of an 18.18% decline suggest momentum has cooled in the short term.

If this blend of consumer finance, health and wellness, and pet care has your attention, it can be a good moment to broaden your watchlist with 20 top founder-led companies

With the stock down 18.18% year to date but still showing a 57.38% 1 year total return, and trading below the average analyst price target and intrinsic value estimates, is Synchrony a mispriced opportunity or already reflecting expectations for future growth?

At a last close of $69.26 versus a fair value narrative of $105, the gap is wide enough that it raises clear questions about what the market is pricing in.

Your DCF/Excess Return analysis suggests Synchrony Financial’s intrinsic value is around $145 per share, meaning the stock could be trading at a steep discount (~40% undervalued) versus its fundamental long-term economic profit potential. Current market pricing and consensus analyst targets are significantly lower, around the mid-$80s to ~$100, mainly because of short-term earnings expectations and risk pricing.

Read the complete narrative.

Want to see what sits behind that valuation gap? The narrative leans on robust profitability, a healthy spread over the cost of equity, and steady long run compounding assumptions. Curious which specific growth, margin, and discount rate inputs pull the fair value up to triple digits? The full breakdown shows exactly how those moving parts stack together.

Result: Fair Value of $105 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, your thesis still faces real swing factors, including a potential spike in credit losses and regulatory shifts that pressure fees or Synchrony’s 36.21% profit margin.

Find out about the key risks to this Synchrony Financial narrative.

This mix of opportunity and concern will mean different things to different investors, so it makes sense to check the numbers yourself and decide where you stand. To see how the upsides and downsides line up before you move on, review the 6 key rewards and 3 important warning signs

If Synchrony has sharpened your thinking, do not stop here. Use the screener to spot other clear opportunities before the crowd gets there.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SYF.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com